The rate of patients that achieved an HbA1c < 7.0% without developing clinically significant or severe hypoglycemia events at week 26 did not differ in patients receiving insulin icodec rather than the control (26% vs. 25%; estimated odds ratio = 1.07; 95%CI: 0.73 to 1.55). Here, INS is linked to Hypoglycemia.